Keywords: visipaque, approved, usa, nycomed, new-generation, contrast, imaging
Visipaque Approved In USA
Article | 29 April 1996
- Nycomed's new-generation contrast imaging agent Visipaque (iodixanol) has been approved for use in X-ray and other imaging modalities in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
